ENTITY
Sinopharm Group

Sinopharm Group (1099 HK)

171
Analysis
Health Care • China
Sinopharm Group is a leading Chinese distributor and retailer of pharmaceutical and healthcare products, medical devices, and a supply chain service provider. The company also engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. It was incorporated in January 2003 and is headquartered in Shanghai, China.
more
•27 Nov 2018 05:23

EM Health Care:  Late Cycle Rotation

Emerging Market Health Care allocations sit towards the lower end of their 7-year range. Current levels are off their 2015 highs by a margin, with...

Logo
475 Views
Share
bullish•COREE
•22 May 2026 08:55

Pre-IPO COREE - The Business Model and the Concerns Behind

​COREE is a key connector for pediatric drugs in China, facing challenge of expanding while maintaining stability. There's signs of deterioration....

Logo
130 Views
Share
•01 Oct 2017 07:26

The Week That Was in Greater China @Smartkarma: Recent IPOs, China NEVs, & ZTO's Weird Q2 Numbers

This issue of 'The Week that Was in Greater China@Smartkarma' covers the week of September 23rd through September 30th and features a selection...

Logo
322 Views
Share
bullish•BeOne Medicines
•22 Apr 2026 18:40

HSI May 2026 Index Review Forecast

HSI May 2026 forecast: we expect BeOne and Zijin Gold to enter, no delete, with Healthcare and EMIC still the clearest sector gaps.

Logo
518 Views
Share
•09 Feb 2017 09:14

Trump Health Effect: What Is Next for the Consumer Health Industry Under Trump's Leadership?

While the US consumer health industry will remain a strong centre for investment, development and technology innovation in 2017 and is expected to...

x